Skip to main content
KA

Kadence Bio

London, United Kingdom
Last funding
$10.0M
Series AJun 2025

Kadence Bio is a clinical-stage life sciences company developing novel treatments for sexual and mental health conditions.

About Kadence Bio

How much funding has Kadence Bio raised?

Kadence Bio has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.

Where is Kadence Bio headquartered?

Kadence Bio is headquartered in London, United Kingdom.

What does Kadence Bio do?

Kadence Bio is a clinical-stage life sciences company developing novel treatments for sexual and mental health conditions.

What stage is Kadence Bio at?

Kadence Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kadence Bio — Funding & Investors." VCBacked, June 1, 2025, https://www.vcbacked.co/company/kadence-bio. Accessed November 14, 2026.
APA
VCBacked. (2025). Kadence Bio — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/kadence-bio
Wikipedia (cite web)
{{cite web |title=Kadence Bio — Funding & Investors |url=https://www.vcbacked.co/company/kadence-bio |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Kadence Bio? Request a listing update

Founder contacts
m***@kadencebio.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →